TachoSil Kamm
Produzent: Takeda Pharma
enthält
TachoSil ist ein Mittel, um die Blutung zu stoppen.Wirkstoffe
Fibrinogen
Menschliches Thrombin
Anwendung
TachoSil wird verwendet fĂĽr:
- Stoppen des lokalen Blutungen in den inneren Organen
- Die Adhäsion von Geweben in der Chirurgie.
- Vermeidung von Leckagen nach der Operation im Gehirn.
Nur in Krankenhäusern verwendet.
Dosierung
Erhältlich als vævsklæbermatrix. Die Dosierung ist individuell.
Mögliche Nebenwirkungen
Häufig (1-10%) | Fieber |
Gelegentlich (0.1-1%) | Ăśberempfindlichkeit |
Selten (0,01-0,1%) | Allergische Reaktionen (anaphylaktischer Schock) |
Sehr selten (weniger als 0,01%) | Blutgerinnsel |
Nicht bekannt | Verstopfung * |
* Verstopfung wird durch Bauchoperationen gesehen.
Schwangerschaft
Sollte aufgrund mangelnder Kenntnisse nicht verwendet werden. Dieser Text unterscheidet sich von den vom Unternehmen genehmigten Produktinformationen (Produktzusammenfassung). Wegen fehlender Kenntnisse nicht verwendet. Dieser Text unterscheidet sich von den vom Unternehmen genehmigten Produktinformationen (ProduktĂĽbersicht).Stillen
Kann bei Bedarf verwendet werden.Verkehr
Keine Warnung.Blutspender
Lass es nicht fallen. 4 Wochen Quarantäne nach Behandlungsende.Wirkung
Funktioniert, weil von Fibrinogen und Thrombin. Das Mittel ergänzen normale Blutspiegel dieser Substanzen, die für die Blutgerinnung notwendig sind.
pharmazeutische Formen
Vævsklæbermatrix. 1 cm2 5,5 mg menschliches Fibrinogen und 2 IU menschlichen Thrombin enthält.
Spezielle Warnungen
Arzneimittel aus menschlichem Blut können die Übertragung von ansteckenden Substanzen nicht vollständig ausschließen.
ZuschĂĽsse, Lieferung, Pakete und Preise
Subventionen | Auslieferung | Dispensform und Stärke | Verpackung | Preis in kr. |
Darf nur an Krankenhäuser geliefert werden. Lieferung gemäß den Bestimmungen für Arzneimittel in der Liefergruppe A | vævsklæbermatrix | 1 Stück 9,5 cm x 4,8 cm | 2.546,20 | |
Darf nur an Krankenhäuser geliefert werden. Lieferung gemäß den Bestimmungen für Arzneimittel in der Liefergruppe A | vævsklæbermatrix | 1 Stück 3 cm x 2,5 cm | 755,30 | |
Darf nur an Krankenhäuser geliefert werden. Lieferung gemäß den Bestimmungen für Arzneimittel in der Liefergruppe A | vævsklæbermatrix | 1 Stück (Prærullet) 4,8cm x4,8cm | 1.754,50 | |
Darf nur an Krankenhäuser geliefert werden. Lieferung gemäß den Bestimmungen für Arzneimittel in der Liefergruppe A | vævsklæbermatrix | 2 Stück 4,8 cm x 4,8 cm | 2.799,10 | |
Darf nur an Krankenhäuser geliefert werden. Lieferung gemäß den Bestimmungen für Arzneimittel in der Liefergruppe A | vævsklæbermatrix | 5 Stück 3,0 cm x 2,5 cm | 3.704,15 |
Farbstoffe
Riboflavin und Riboflavin-5'-phosphat (E101)
FAQ - 💬❓ What is TachoSil used for?👉 TachoSil is a fibrin sealant patch indicated for use with manual compression in adult and pediatric patients as an adjunct to hemostasis in cardiovascular and hepatic surgery when control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical. ❓ What is TachoSil made of?👉 TachoSil contains fibrinogen and thrombin as a dried coating on the surface of a collagen matrix. In contact with physiological fluids, e.g. blood, lymph or physiological saline solution the components of the coating dissolve and partly diffuse into the wound surface. ❓ What is the absorption time of TachoSil?👉 TachoSil will be enzymatically degraded and safely absorbed by the body within 12 weeks of application. ❓ Is TachoSil a medical device?👉 TachoSil is a surgical patch used by medical professionals for bleeding control. ❓ How to apply TachoSil?👉 TachoSil should only be applied directly onto the treatment site so that it covers 1 to 2 cm beyond the edge of the wound. The amount of TachoSil to be used depends on the size of the wound and the material can be cut to size if needed. TachoSil must not be applied inside a blood vessel. ❓ Where is TachoSil manufactured?👉 Linz, AustriaTakeda will continue to maintain the ownership of TachoSil's manufacturing facility located in Linz, Austria. The company has also entered a long-term manufacturing and supply agreement, under which it will continue to exclusively manufacture TachoSil products and supply them to Corza. ❓ Who makes TachoSil?👉 Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. ❓ Who makes Tachosil?👉 Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. ❓ What is FloSeal sealant?👉 FloSeal® (Baxter, Deerfield, IL, USA) is a biodegradable matrix haemostatic sealant composed of gelatin granules and human thrombin. It is applied to a bleeding site topically as a high-viscosity gel. Initial research showed promising results in controlling bleeding in cardiac, vascular and spinal surgery. ❓ How do you use tisseel glue?👉 TISSEEL must be sprayed only onto application sites that are visible. Dry the site of application as much as possible. The surface area of the wound needs to be dried using standard techniques (e.g. intermittent application of compresses, swabs, use of suction devices). ❓ Is TachoSil synthetic?👉 We selected Duraseal and Tachosil because they had regulatory approval and represent both types of sealant groups, synthetic and fibrin sealants respectively. ❓ What is TachoSil used for?👉 TachoSil is a sponge sealant patch that is coated with the active substances human fibrinogen and human thrombin. TachoSil is used in adults: during an operation, to stop bleeding and to seal the surfaces of internal organs; as support to stitching during surgery on the blood vessels; ❓ When was TachoSil approved by the FDA?👉 Tachosil received FDA approval on April 6, 2010 for Baxter & Nycomed as a hemostatic product to be used during cardiovascular and hepatic surgery. TachoSil is a Fibrin Sealant Patch comprised of human fibrinogen and human thrombin coated onto an equine collagen sponge. ❓ Is TachoSil sold to Corza?👉 Osaka, JAPAN, February 1, 2021 – Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has completed the previously announced sale of TachoSil ® Fibrin Sealant Patch (“TachoSil ® ”) to Corza Health, Inc. (“Corza”) for €350 million. ❓ How do I apply TachoSil to my wound?👉 TachoSil should only be applied directly onto the treatment site. The sponge should be applied so that it covers 1 to 2 cm beyond the edge of the wound. The number amount of TachoSil to be sponges used depends on the size of the wound. |